Palvella Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
PVLA
CUSIP
697947109
Type
Equity
Class
COM
Num filers
66
Total reported value, excl. options
$133M
Manager Report Date Value ($000) Shares